New Edge Advisors, LLC Medicinova Inc Transaction History
New Edge Advisors, LLC
- $16 Billion
- Q4 2024
A detailed history of New Edge Advisors, LLC transactions in Medicinova Inc stock. As of the latest transaction made, New Edge Advisors, LLC holds 3 shares of MNOV stock, worth $4. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$4% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding MNOV
# of Institutions
29Shares Held
5.13MCall Options Held
0Put Options Held
0-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.77 Million0.54% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.11 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA623KShares$997,3320.0% of portfolio
-
Geode Capital Management, LLC Boston, MA515KShares$823,8620.0% of portfolio
-
Citigroup Inc502KShares$803,1310.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $78.5M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...